Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated
NCT ID: NCT02069067
Last Updated: 2023-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2011-12-31
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy
NCT02443675
Vulnerability and Risk of Neuropathic Pain in Cancer
NCT06511674
Development of an Intervention to Enhance Cancer Pain Management
NCT03752268
An Internet-based Program to Help Cancer Survivors Manage Pain
NCT04462302
Early Interventional Treatment for Cancer Pain
NCT05366413
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Advanced cancer patients with pain
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic pain controlled for at least one week with opioids 60 mg / day morphine equivalent
* 1-6 episodes of BTcP within any of 3 days previous to registration into study
* Signed Informed Consent
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Naples
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arturo Cuomo, M.D.
Role: PRINCIPAL_INVESTIGATOR
NCI Naples, Division of Pain Therapy
Francesco Perrone, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
NCI Naples, Clinical Trials Unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ospedale San Leonardo
Castellammare di Stabia, , Italy
Istituto Nazionale dei Tumori , Unita Terapia Antalgica
Napoli, , Italy
S. Maria della Pietà
Nola, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Break-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.